Would be nice to see another update from the Management team.
"Testing for osteogenic differentiation revealed enhanced osteogenic
differentiation capabilities.
The project is now set to advance to in vivo studies of biological models, to gauge
the efficacy of bone regeneration.
“While we continue to prioritise our objective of commercialising our current products, we are
looking forward to working on new technologies – such as the next-generation jaw implant –
which supports our long-term vision of becoming the global leader in regenerative medicine,”
said Dr Lim.
The global dental bone graft and membrane substitutes market was valued at USD$11.47
billion in 2023, with a projected value of USD$27.55 billion by 2030."
- Forums
- ASX - By Stock
- Ann: A$18.7m Osteopore, NDCS and A*STAR project hits milestones
Would be nice to see another update from the Management...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSX (ASX) to my watchlist
|
|||||
Last
4.4¢ |
Change
0.002(4.76%) |
Mkt cap ! $5.084M |
Open | High | Low | Value | Volume |
4.1¢ | 4.4¢ | 4.1¢ | $46.74K | 1.112M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5571 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 193310 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5571 | 0.043 |
1 | 1319459 | 0.042 |
4 | 435000 | 0.040 |
1 | 25641 | 0.039 |
2 | 578945 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 193310 | 2 |
0.045 | 51600 | 2 |
0.047 | 210000 | 2 |
0.048 | 15000 | 1 |
0.049 | 568500 | 6 |
Last trade - 15.53pm 02/09/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |